Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2021-05-10 2018-09-08
Drug Identification Number 02254522 02254522
Brand name APO-QUININE APO-QUININE
Common or Proper name QUININE QUININE
Company Name APOTEX INC APOTEX INC
Ingredients QUININE SULFATE QUININE SULFATE
Strength(s) 300MG 300MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code P01BC P01BC
ATC description ANTIMALARIALS ANTIMALARIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-09-12 2019-09-12
Actual discontinuation date 2020-09-30
Remaining supply date 2019-09-12 2019-09-12
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments